GemPharmatech Co

GemPharmatech Co Diluted EPS

The Diluted Earnings per Share of GemPharmatech Co (688046.SS) as of Oct 18, 2026 is 0.35 CNY. In the previous year, Diluted Earnings per Share was 0.27 CNY — a change of 29.88% (higher).

Diluted EPS

0.35CNY

YoY

29.88%

Last updated:

Diluted Earnings per Share of GemPharmatech Co is 2025 0.35 CNY. Diluted Earnings per Share of GemPharmatech Co was 2024 0.27 CNY. It decreases by 29.88% higher compared to the previous year.

The GemPharmatech Co Diluted EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Diluted EPS
Date
Diluted EPS
Jan 1, 2018
-0.01 CNY
Jan 1, 2019
0.08 CNY
Jan 1, 2020
0.19 CNY
Jan 1, 2021
0.30 CNY
Jan 1, 2022
0.40 CNY
Jan 1, 2023
0.39 CNY
Jan 1, 2024
0.27 CNY
Jan 1, 2025
0.35 CNY
The GemPharmatech Co Diluted EPS history
YEARDiluted EPSYoY
0.35CNY+29.88%
0.27CNY-30.89%
0.39CNY-3.49%
0.40CNY+31.81%
0.30CNY+63.45%
0.19CNY+119.99%
0.08CNY-676.48%
-0.01CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

GemPharmatech Co Stock analysis

What does GemPharmatech Co do? GemPharmatech Co Ltd, based in Nanjing, China, operates in the Health Care sector within the Life Sciences Tools & Services industry. The company develops and sells experimental mouse models using gene-editing and other advanced technologies. It provides customized model breeding, drug efficacy analysis, and model customization services. With 1,342 employees, GemPharmatech serves research needs in gene function, disease mechanisms, and drug target discovery, supporting fundamental research in life sciences. GemPharmatech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about GemPharmatech Co stock

Diluted Earnings per Share of GemPharmatech Co is 0.35 CNY in 2025.

Diluted Earnings per Share of GemPharmatech Co changed from 0.27 CNY to 0.35 CNY, representing a 29.88% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Diluted Earnings per Share GemPharmatech Co since 2006 – with annual values, charts, and detailed analysis.

Diluted EPS accounts for all potential shares from options, warrants, and convertible securities. It provides a more conservative per-share earnings measure.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — GemPharmatech Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — GemPharmatech Co